Alan Grujic - 21 Aug 2025 Form 4 Insider Report for GUIDED THERAPEUTICS INC (GTHP)

Reporting relationship: Director
Issuer ticker: GTHP
Reported as of: 21 Aug 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 05 Sep 2025, 16:25:49 UTC
Prior SEC filing: 12 Jun 2025
Next SEC filing: 07 Apr 2026
Source filing: View source filing
Reporting owner signature: /s/ Alan Grujic

Key filing fact

Alan Grujic filed Form 4 for GUIDED THERAPEUTICS INC (GTHP) on 05 Sep 2025.

Key facts

This page summarizes Alan Grujic's Form 4 filing for GUIDED THERAPEUTICS INC (GTHP).
5 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 05 Sep 2025, 16:25.

Change

Previous filing in this sequence was filed on 12 Jun 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001980904 Primary reporting owner

Grujic Alan

Relationship: Director
Address: 5835 PEACHTREE CORNERS EAST, SUITE B, PEACHTREE CORNERS
Signature: /s/ Alan Grujic
Signature date: 04 Sep 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

GTHP transaction

Common Stock

Other

Transaction value
Shares: +17,408
Change %: +1.2%
Price
Shares after: 1,465,433
Date: 21 Aug 2025
Ownership: Direct
Footnotes: F1

GTHP transaction

Preferred Series E Stock

Other

Transaction value
Shares: -50
Change %: -100%
Price
Shares after: 0
Date: 21 Aug 2025
Ownership: Direct
Footnotes: F2

GTHP transaction

Common Stock

Other

Transaction value
Shares: +200,000
Change %: +14%
Price
Shares after: 1,665,433
Date: 21 Aug 2025
Ownership: Direct
Footnotes: F2

GTHP transaction

Common Stock

Purchase

Transaction value
Shares: +152,108
Change %: +9.1%
Price
Shares after: 1,817,541
Date: 29 Aug 2025
Ownership: Direct
Footnotes: F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

GTHP transaction Derivative

Warrants

Purchase

Transaction value
Shares: +152,108
Change %: +608%
Price
Shares after: 177,108
Date: 29 Aug 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 152,108
Exercise price: $0.2500
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

These shares were issued for payment of accrued dividends on the reporting individual's Series E preferred stock, at a conversion price of $0.2298.

Footnote F2

On August 21, 2025, Mr. Grujic converted 50 shares of Series E preferred stock into 200,000 shares of common stock. The Series E preferred stock had a stated value of $1,000 and $0.25 conversion price.

Footnote F3

On August 29, 2025, the Company closed on Tranche 4 Private Financing. The Company simultaneously entered into a Securities Purchase Agreement and an exchange agreement with Mr. Grujic, whereby Mr. Grujic agreed to exchange a $25,000 note payable and accrued interest of $2,379.45 for an aggregate of 152,108 units, each unit consisting of one share of common stock and one warrant to purchase up to 152,108 shares of common stock (the "August Warrants"). The August Warrants were immediately exercisable upon issuance and will expire in four years following the issuance date and have an exercise price of $0.25 per share.